Press Release Contact Form

Revalesio Initiates Phase IIa Study of RNS60 in Multiple Sclerosis at University Hospital Zurich

Your message will be sent directly to the press release author.

Your Name:
Email Address:
Company:
Message:
Verification: Please enter any two digits with no spaces (Example: 12)